Recent News & Events
Recent News
Recent Events
05 02/2024
Outcome of Board Meeting
13 01/2024
Disclosure under Regulation 31A(8)(d)
14 11/2023
Disclosure under Regulation 31A
29
09/2023
Outcome of Board Meeting
29
09/2023
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015
Download
Download
26
09/2023
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015
Download
07
08/2023
Schedule of Conference Call for Investors on August 10, 2023
Download
19
05/2023
Schedule of Conference Call for Investors on May 26, 2023
Download
08
03/2023
Disclosure under Regulation 30 of LODR
Download
31
01/2023
Schedule of Conference Call for Investors on February 7, 2023
Download
30
12/2022
Conference Call Transcript on December 26, 2022
27
12/2022
Conference Call Audio on December 26, 2022
Download
26
12/2022
Schedule of Conference Call for Investors on December 26, 2022
Download
26
12/2022
Disclosure under Regulation 30
Download
03
11/2022
Schedule of Conference Call for Investors on November 9, 2022
Download
04
10/2022
Casper Pharma Receives EIR from USFDA for its PAI (pre-approval inspection)
Download
02
09/2022
Outcome of the Board Meeting
Download
04
08/2022
08/2022
Schedule of Conference Call for Investors on August 08, 2022
Download
30
07/2022
07/2022
Casper Pharma completed USFDA pre-approval inspection
Download
08
06/2022
06/2022
Transcript of the earnings for the Analyst Meet on June 01, 2022
Download
02
06/2022
06/2022
Analyst Meet Audio recording on June 01, 2022
Download
31
05/2022
05/2022
Schedule of Analyst Meet on June 01, 2022
Download
05
05/2022
05/2022
Schedule of Conference Call for Investors on May 10, 2022
Download
Download
05
04/2022
04/2022
SUVENPHARM Outcome of Board Meeting 05-04-2022
14
12/2021
SUVENPHARM Outcome of Board Meeting 14-12-2021
10
06/2021
SUVENPHARM News Release 10062021
03
04/2020
SUVENPHARM Outcome of Board Meeting 14-12-2021
25
03/2020
03/2020
SUVENPHARCovidNewsRelease25032020
Download